STOCK TITAN

Aquestive: Five entities report zero share ownership

Douglas K. Bratton is reported with 691,873 beneficially owned shares, including 54,050 shares he can acquire under vested director stock options.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Aquestive Therapeutics, Inc. (AQST) ownership disclosures report that five MonoLine entities distributed shares to their owners. MonoLine RX II distributed 3,468,747 shares, MonoLine RX III 2,657,943 shares, MonoLine RX 1,688,639 shares and MonoSol RX Genpar 47,051 shares between October 2 and October 7, 2026; MonoLine Partners distributed 1,948,578 shares on October 2, 2026. Each entity is listed with zero beneficial ownership.

Douglas K. Bratton is reported as beneficial owner of 691,873 shares, approximately 0.6% of the outstanding shares. This amount includes 54,050 shares he currently has the right to acquire under vested director stock options. The report lists his sole voting and dispositive power over 637,823 shares.

Shares distributed by MonoLine RX II 3,468,747 shares Distributed to its owners between October 2 and October 7, 2026
Shares distributed by MonoLine RX III 2,657,943 shares Distributed to its owners between October 2 and October 7, 2026
Shares distributed by MonoLine RX 1,688,639 shares Distributed to its owners between October 2 and October 7, 2026
Shares distributed by MonoLine Partners 1,948,578 shares Distributed to its owners on October 2, 2026
Shares distributed by MonoSol RX Genpar 47,051 shares Distributed to its owners between October 2 and October 7, 2026
Douglas K. Bratton beneficial ownership 691,873 shares Includes shares he has the right to acquire under vested director stock options
Shares subject to vested director stock options 54,050 shares Shares Douglas K. Bratton currently has the right to acquire
Douglas K. Bratton sole voting and dispositive power 637,823 shares As reported in the ownership disclosure
beneficial owner regulatory
"beneficial owner of an aggregate of 691,873 shares"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
sole power to vote regulatory
"sole power to vote or to direct the vote"
sole power to dispose regulatory
"sole power to dispose or to direct the disposition"
vested director stock options financial
"54,050 shares that DKB currently has the right to acquire under vested director stock options"
general partner financial
"Bratton Capital Inc., which is the general partner of Bratton Capital Management L.P."
A general partner is the person or firm that runs an investment partnership and legally represents it — they make the day-to-day decisions, choose which assets to buy or sell, and are responsible for the partnership’s obligations. Investors care because the general partner’s judgment, risk-taking and fee and profit-sharing arrangements determine both the potential returns and the level of exposure to losses; think of the GP as the ship’s captain whose skill and honesty shape the voyage’s outcome.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AQST shares did the MonoLine entities distribute?

MonoLine RX II distributed 3,468,747 shares, MonoLine RX III distributed 2,657,943, MonoLine RX distributed 1,688,639 and MonoSol RX Genpar distributed 47,051 between October 2 and October 7, 2026. MonoLine Partners distributed 1,948,578 shares on October 2, 2026.

How many AQST shares does Douglas K. Bratton beneficially own?

Douglas K. Bratton is reported as beneficial owner of 691,873 shares, approximately 0.6% of the outstanding shares. The amount includes 54,050 shares he currently has the right to acquire under vested director stock options; his sole voting and dispositive power is listed over 637,823 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





03843E104

(CUSIP Number)
10/07/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: 390,795 shares are held by Bratton Capital Management L.P.; 875 shares are held by Bratton Capital Inc.; and 33,727 shares are held by Bratton Family Partners L.P. In his capacity as (i) the sole director and President of Bratton Capital Inc., which is the general partner of Bratton Capital Management L.P., Douglas K. Bratton ("DKB"), exercises voting and dispositive power over an aggregate of 391,670 shares held by Bratton Capital Inc. and Bratton Capital Management L.P. and (ii) the sole director and President of DKB Management, Inc., which is the general partner of Bratton Family Partners L.P., DKB exercises voting and dispositive power over the 33,727 shares held by Bratton Family Partners L.P. The number 637,823 also includes 212,426 shares owned directly by DKB or by family trusts and entities. The number 691,873 includes 212,426 shares either owned directly by DKB or held by family trusts and entities, and 54,050 shares that DKB currently has the right to acquire under vested director stock options. It does not include 2,727 shares owned by DKB's spouse, with respect to which DKB disclaims beneficial ownership.


SCHEDULE 13G




Comment for Type of Reporting Person: Between October 2, 2026 and October 7, 2026, MonoLine RX II, L.P. distributed the 3,468,747 shares held by it to its owners.


SCHEDULE 13G




Comment for Type of Reporting Person: Between October 2, 2026 and October 7, 2026, MonoLine RX III, L.P. distributed the 2,657,943 shares held by it to its owners.


SCHEDULE 13G




Comment for Type of Reporting Person: Between October 2, 2026 and October 7, 2026, MonoLine RX, L.P. distributed the 1,688,639 shares held by it to its owners.


SCHEDULE 13G




Comment for Type of Reporting Person: On October 2, 2026, MonoLine Partners, L.P. distributed the 1,948,578 shares held by it to its owners.


SCHEDULE 13G




Comment for Type of Reporting Person: Between October 2, 2026 and October 7, 2026, MonoSol RX Genpar, L.P. distributed the 47,051 shares held by it to its owners.


SCHEDULE 13G





SCHEDULE 13G




Comment for Type of Reporting Person: 390,795 shares are held by Bratton Capital Management L.P. In its capacity as the general partner of Bratton Capital Management L.P., Bratton Capital Inc. exercises voting and dispositive power over such shares. 875 shares are held by Bratton Capital Inc. directly.


SCHEDULE 13G





SCHEDULE 13G



BRATTON DOUGLAS K
Signature:/s/ Douglas K. Bratton
Name/Title:Self
Date:10/07/2026
MonoLine RX II, L.P.
Signature:/s/ John Cochran
Name/Title:Vice President of General Partner of General Partner
Date:10/07/2026
MonoLine RX III, L.P.
Signature:/s/ John Cochran
Name/Title:Vice President of General Partner of General Partner
Date:10/07/2026
MonoLine RX, L.P.
Signature:/s/ John Cochran
Name/Title:Vice President of General Partner of General Partner
Date:10/07/2026
MonoLine Partners, L.P.
Signature:/s/ John Cochran
Name/Title:Vice President of General Partner of General Partner
Date:10/07/2026
MonoSol Rx Genpar, L.P.
Signature:/s/ John Cochran
Name/Title:Vice President of General Partner
Date:10/07/2026
Bratton Capital Management, L.P.
Signature:/s/ John Cochran
Name/Title:Vice President of General Partner
Date:10/07/2026
Bratton Capital Inc.
Signature:/s/ John Cochran
Name/Title:Vice President
Date:10/07/2026
Bratton Family Partners L.P.
Signature:/s/ Phil Null
Name/Title:Vice President of General Partner
Date:10/07/2026

Keep reading